[7] Liraglutide led to greater weight loss than some previous glucagon-like peptide analogues, [11] but is less effective than the standard weight loss dose of semaglutide
If clinical suspicion exists based on history or examination findings, appropriate evaluationpotentially including thyroid ultrasound, serum calcitonin, or genetic testing for RET mutationsshould be completed before starting therapy
References Jones, J
Abubakar M, Nama L, Ansari MA, Ansari MM, Bhardwaj S, Daksh R, Syamala KLV, Jamadade MS, Chhabra V, Kumar D, Kumar N (2024) GLP-1/GIP Agonist as an Intriguing and Ultimate Remedy for Combating Alzheimers Disease through its Supporting DPP4 Inhibitors: A Review
Obesity itself is associated with altered cortisol clearance and tissue-specific cortisol activation through 11-hydroxysteroid dehydrogenase type 1
practices for producing drug products intended or expected to be sterile, which put patients at risk. [15] FDA also recently took action against a compounding facility that sold misbranded weight loss products, including semaglutide, and manufactured products in insanitary conditions